Hospital Phlebotomy Supplies: Top U.S. Distributors, Manufacturers, and Buying Guide
Summary
- Major U.S. healthcare distributors, including McKesson Medical-Surgical, Medline, Cardinal Health, and Henry Schein Medical, offer broad portfolios of hospital-grade phlebotomy supplies from established manufacturers.
- Manufacturers such as Becton, Dickinson and Company, Greiner Bio-One, Terumo, Sarstedt, and Puritan provide blood collection tubes, needles, safety devices, transport products, and related equipment used in hospitals and clinical laboratories.
- Hospitals should evaluate suppliers by regulatory compliance, product compatibility, safety-engineering features, supply continuity, total cost, and documentation rather than relying only on the phrase “hospital-grade.”
Hospitals, physician practices, diagnostic laboratories, blood banks, urgent-care centers, and mobile collection services purchase phlebotomy supplies every day. These products include evacuated blood collection tubes, needles, syringes, winged blood collection sets, tourniquets, Blood Culture bottles, specimen labels, sharps containers, transport bags, and personal protective equipment.
In the United States, buyers can purchase these supplies directly from manufacturers or through large medical-surgical distributors. The best source depends on the organization’s size, testing menu, contract structure, inventory requirements, and preference for standardized products. A small outpatient clinic may purchase through a distributor’s online catalog, while a large hospital system may negotiate a multiyear agreement involving multiple facilities, automated replenishment, and laboratory-interface support.
It is also important to understand that “hospital-grade” is not a single legal designation applied to every phlebotomy product. In practice, the phrase usually refers to products designed, documented, and supplied for professional clinical use. Buyers should verify the applicable U.S. Food and Drug Administration requirements, product labeling, sterility claims, lot information, expiration dates, safety features, and compatibility with the organization’s laboratory instruments and procedures.
The U.S. Market for Phlebotomy Supplies
The demand for blood collection products is linked to the size and activity of the American healthcare system. The American Hospital Association has reported that the United States has more than 6,000 hospitals, including community hospitals, specialty hospitals, federal facilities, and other categories of inpatient institutions. Those facilities collectively handle tens of millions of admissions and more than a billion outpatient visits in a typical year. Each encounter may generate one or more laboratory orders.
Clinical laboratories also process a very large volume of tests. Federal healthcare data consistently show that laboratory testing represents a substantial share of medical diagnostic activity, with blood-based testing supporting emergency care, inpatient monitoring, cancer treatment, chronic disease management, infectious-disease diagnosis, and preventive screening. Even a modest reduction in redraws can therefore create meaningful savings in labor, supplies, patient discomfort, and turnaround time.
Phlebotomy procurement has become more complex since the supply disruptions experienced during the Covid-19 pandemic. Hospitals now pay closer attention to dual sourcing, domestic manufacturing, safety-stock levels, allocation policies, transportation capacity, and supplier communication. A low unit price is useful, but it does not compensate for repeated back orders or the need to change collection systems without adequate validation and staff training.
Large U.S. Medical-Surgical Distributors
Large distributors are often the most convenient purchasing channel for hospitals that need multiple categories of supplies from one account. They generally offer electronic ordering, contract pricing, private-label products, inventory-management services, consolidated billing, and delivery to multiple locations.
McKesson Medical-Surgical
McKesson Medical-Surgical is one of the largest healthcare distributors serving hospitals, clinics, laboratories, physician offices, and other care providers in the United States. Its catalog typically includes blood collection tubes, needles, syringes, safety devices, specimen containers, gloves, disinfectants, sharps containers, labels, and other laboratory and medical-surgical products.
McKesson can be useful for organizations that want to consolidate orders and manage a broad medical-supply portfolio through one distribution relationship. Buyers may be able to purchase national-brand products as well as distributor or private-label alternatives, subject to availability and contract terms. Hospitals should ask whether a quoted product is manufactured by a named brand, whether substitutions are permitted, and whether the product is covered by an existing group purchasing organization agreement.
For phlebotomy departments, important evaluation questions include the distributor’s inventory position, allocation procedures, delivery schedule, lot-traceability process, return policy, and ability to support multiple tube sizes and additive types. A product that appears similar in a catalog may not be interchangeable with the tube or needle already validated by a laboratory.
Medline
Medline is a major American medical-supply manufacturer and distributor with a broad portfolio used by hospitals, ambulatory centers, long-term-care organizations, laboratories, and physician practices. Its offerings commonly include blood collection products, safety needles, syringes, specimen transport supplies, personal protective equipment, disinfectants, exam gloves, procedure trays, and storage products.
One advantage of working with Medline is the ability to combine phlebotomy supplies with related clinical products. A health system may coordinate products for the entire specimen-collection Workflow, including gloves, antiseptic preparations, gauze, bandages, labels, transport bags, and sharps disposal. Medline also works with healthcare organizations on inventory-management and supply-chain programs, which can be valuable for facilities with high usage or multiple campuses.
When comparing Medline products with other brands, procurement teams should look beyond the catalog description. They should request technical data sheets, instructions for use, sterility information, packaging specifications, and evidence that the products meet the laboratory’s collection and transportation requirements.
Cardinal Health
Cardinal Health is another major U.S. healthcare distributor serving hospitals, laboratories, ambulatory facilities, and other providers. Its medical and laboratory product categories include blood collection systems, safety-engineered devices, specimen containers, syringes, needles, exam gloves, disinfectants, and sharps-management products.
Cardinal Health may be particularly attractive to hospital systems that already use its distribution, inventory, or pharmaceutical services. Consolidated purchasing can reduce the number of invoices and deliveries, although the lowest total cost depends on contract pricing, freight terms, minimum-order policies, and product availability.
Hospitals evaluating Cardinal Health should confirm how substitutions are handled during shortages. A different tube manufacturer may use a different vacuum level, stopper material, fill tolerance, Clot Activator, gel formulation, or tube geometry. Those differences can affect analyzer performance, Specimen Integrity, and laboratory validation requirements.
Henry Schein Medical
Henry Schein Medical supplies physician practices, outpatient clinics, specialty offices, community health organizations, and other Healthcare Providers. Its portfolio includes blood-drawing needles, evacuated tubes, syringes, specimen containers, safety devices, gloves, antiseptics, and related clinical supplies.
Henry Schein is often a practical option for smaller hospitals, multispecialty practices, urgent-care centers, and independent laboratories that need professional-grade products without maintaining a large direct relationship with several manufacturers. Its catalog-based model can simplify routine reordering, especially for organizations that do not have the purchasing volume required for direct manufacturer contracts.
Buyers should verify whether the requested item is stocked domestically, whether it is available under a contracted price, and whether the catalog listing identifies a specific manufacturer and model. For critical collection products, generic descriptions such as “serum tube” or “safety blood collection set” are not sufficient for a purchase specification.
Leading Manufacturers of Hospital Phlebotomy Products
Many hospitals buy through distributors, but the products themselves are manufactured by specialized diagnostic and medical-device companies. Direct purchasing may be appropriate for large laboratories, integrated delivery networks, blood centers, and organizations seeking standardization across many sites.
Becton, Dickinson and Company
Becton, Dickinson and Company, commonly known as BD, is one of the most recognized manufacturers of blood collection and injection products. Its portfolio includes evacuated blood collection tubes, safety needles, winged blood collection sets, holders, syringes, Blood Culture collection products, and other specimen-collection devices.
BD’s Vacutainer product family is widely used in American hospitals and laboratories. Depending on the specific product, the system may include tubes for serum, plasma, whole blood, coagulation testing, trace-element testing, blood-bank testing, and molecular or specialized applications. BD also offers safety-engineered devices intended to reduce occupational exposure to blood and other potentially infectious materials.
When purchasing BD products, a laboratory should identify exact catalog numbers and tube configurations. Color coding is helpful but should not be the sole basis for selection because color conventions can vary by manufacturer and application. The buyer should confirm additive, fill volume, expiration date, specimen type, centrifugation instructions, and compatibility with the instruments used by the laboratory.
Greiner Bio-One
Greiner Bio-One is an international manufacturer with a significant presence in the U.S. clinical laboratory and healthcare market. Its VACUETTE product line includes evacuated blood collection tubes, needles, holders, safety devices, urine products, capillary collection products, and preanalytical laboratory supplies.
Greiner Bio-One products are used in hospitals, reference laboratories, outpatient collection centers, and research settings. The company’s portfolio includes serum, plasma, coagulation, hematology, blood-bank, and specialty tubes. It also manufactures safety products designed to support safer specimen collection.
Greiner Bio-One can be considered by organizations looking for an alternative to other major evacuated-tube systems. However, conversion should be managed carefully. A laboratory may need to compare tube performance, establish acceptable specimen volumes, review stability data, and perform method or instrument verification before changing brands.
Terumo Blood and Cell Technologies
Terumo Blood and Cell Technologies supplies products for blood collection, transfusion medicine, therapeutic apheresis, and cellular technologies. Its products are especially relevant to blood centers, transfusion services, and hospitals with specialized blood-collection operations.
For routine Venipuncture, Terumo may be considered for needles, blood collection sets, and related devices, while its broader portfolio supports blood-component collection and processing. Buyers should distinguish between products intended for routine diagnostic specimen collection and those intended for blood donation or component processing. The regulatory, operational, and Training Requirements may differ substantially.
Blood centers and hospital transfusion services should evaluate tubing sets, Anticoagulant systems, collection containers, sterile connections, labeling, storage, and traceability. Procurement decisions in this area should involve transfusion medicine specialists and quality-management personnel rather than relying solely on general purchasing criteria.
Sarstedt
Sarstedt manufactures laboratory and medical products, including blood collection tubes, needles, urine containers, specimen transport products, and other preanalytical supplies. Its products are distributed in the United States through authorized channels and are used by clinical laboratories and healthcare facilities.
Sarstedt may be a suitable supplier for organizations interested in broad specimen-collection solutions or an alternative evacuated-tube platform. As with any system conversion, the laboratory should examine tube additives, serum or plasma yield, clotting behavior, gel separation, transport conditions, and analyzer compatibility.
Special attention is warranted for coagulation testing. Citrate tubes require correct fill volume and proper blood-to-Anticoagulant ratios. Underfilled tubes, delays in processing, or improper mixing can affect results. Procurement teams should make sure that staff education and collection procedures are updated when a new product is introduced.
Puritan Medical Products
Puritan Medical Products is a U.S. manufacturer known for specimen-collection swabs and related products. Although swabs are not traditional Venipuncture supplies, they are part of the broader specimen-collection Workflow in many hospitals and laboratories.
Puritan became especially prominent during the Covid-19 testing response, when the federal government and healthcare systems focused on expanding domestic production of collection products. Hospitals purchasing nasopharyngeal, oral, or other swabs should confirm the intended test application, transport medium, sterility, packaging, and compatibility with the testing platform.
For organizations purchasing both blood-draw supplies and swab-based collection products, Puritan may be considered as part of a diversified domestic sourcing strategy. The relevant product category and intended use should always be specified precisely.
Products Commonly Purchased for Hospital Phlebotomy
A complete phlebotomy purchasing program normally covers more than needles and tubes. The following categories are commonly included in hospital supply contracts:
- Evacuated blood collection tubes for serum, plasma, hematology, coagulation, blood-bank, chemistry, and specialty testing.
- Safety needles, straight needles, butterfly or winged sets, needle holders, and syringe-based collection devices.
- Blood Culture collection bottles and accessories for aerobic and anaerobic cultures.
- Tourniquets, antiseptic wipes, Chlorhexidine or alcohol preparations, gauze, adhesive bandages, and specimen labels.
- Gloves, protective eyewear, gowns, masks, and other personal protective equipment.
- Sharps containers and disposal systems that comply with applicable workplace and waste-management requirements.
- Specimen bags, absorbent materials, secondary containers, racks, pneumatic-tube accessories, and temperature-control packaging.
- Capillary collection products for neonates, pediatrics, patients with difficult venous access, and Point-Of-Care Testing.
- Phlebotomy trays, carts, procedure kits, and barcode-based identification supplies.
- Training materials, quality-control products, and equipment used to support Specimen Integrity and staff competency.
Regulatory and Safety Considerations
The Occupational Safety and Health Administration’s Bloodborne Pathogens Standard requires employers with occupational exposure to blood or other potentially infectious materials to use appropriate controls, provide training, and maintain an exposure-control plan. The standard also addresses engineering controls, work-practice controls, personal protective equipment, housekeeping, hepatitis B vaccination, post-exposure evaluation, and recordkeeping.
Safety-engineered needles and other sharps devices are important because Needlestick Injuries remain a recognized occupational hazard. The Centers for Disease Control and Prevention has stated that healthcare workers experience hundreds of thousands of needlestick and other percutaneous injuries annually, although estimates vary by setting and reporting method. The true number may be higher because not every incident is reported.
The Needlestick Safety and Prevention Act strengthened federal requirements for evaluating and using safer medical devices. Hospitals should involve frontline clinicians in the selection of safety devices and document the process. A safety feature that is difficult to activate, creates awkward handling, or interferes with collection technique may not deliver the intended benefit.
The Food and Drug Administration regulates many blood collection devices as medical devices. Depending on the product, manufacturers may need to meet requirements related to registration, listing, labeling, quality systems, performance, and premarket review. Buyers should request the manufacturer’s regulatory information and verify that the product is labeled for the intended use.
Clinical laboratories operating under the Clinical Laboratory Improvement Amendments must also maintain procedures that protect specimen quality and test accuracy. The Centers for Medicare and Medicaid Services administers CLIA, while accrediting organizations may impose additional requirements. A purchasing decision that changes tubes, collection devices, transport conditions, or processing steps can affect the laboratory’s validated procedure and may require verification before routine use.
How to Evaluate a Supplier
Confirm the Exact Product Specification
Purchasing departments should avoid vague descriptions. A strong specification identifies the device type, Needle Gauge and length, tubing length, tube material, additive, draw volume, closure color, sterility status, safety mechanism, packaging quantity, and intended specimen type.
For example, “lavender-top tube” is not a complete specification. The buyer should identify whether the tube contains EDTA, the required draw volume, the material, the acceptable testing applications, and the analyzer or laboratory method for which it has been evaluated.
Review Quality and Regulatory Documentation
Suppliers should be able to provide instructions for use, safety data where applicable, product specifications, certificates or declarations relevant to the device, lot information, expiration requirements, and complaint or recall procedures. Hospitals should also establish a process for reviewing manufacturer notifications and product recalls.
Quality documentation is particularly important for Blood Culture products, coagulation tubes, blood-bank products, pediatric devices, and products used for molecular or trace-element testing. These applications can be sensitive to contamination, additive carryover, environmental exposure, and improper fill volume.
Assess Supply Continuity
Recent disruptions have shown that hospitals cannot assume every catalog item will remain continuously available. A supplier evaluation should examine manufacturing locations, distribution centers, lead times, allocation policies, alternative products, emergency-order procedures, and communication during shortages.
Hospitals may benefit from a formal criticality ranking. High-criticality items might include Blood Culture bottles, coagulation tubes, safety needles, pediatric collection devices, and products required for blood-bank testing. These products may require higher safety-stock targets or an approved secondary source.
Compare Total Cost Rather Than Unit Price
The total cost of a phlebotomy product includes more than the invoice price. It may include freight, storage, product waste, staff training, conversion costs, redraws, Specimen Rejection, Needlestick Injuries, disposal, and laboratory validation.
For example, a tube that costs slightly less but produces more hemolysis or insufficient-volume specimens may increase expenses elsewhere. Similarly, a safety needle with a higher purchase price may reduce injury risk and associated administrative and medical costs. Buyers should use quality and operational data when calculating value.
Check Compatibility With Existing Systems
Compatibility must be reviewed at several levels. Tubes need to work with analyzers, centrifuges, racks, barcode systems, pneumatic-tube transport, and laboratory information systems. Needle and holder combinations need to fit correctly and function as intended. Labels need to scan reliably and withstand refrigeration, freezing, moisture, and transport.
Before a large purchase, the laboratory should conduct a controlled evaluation. The evaluation may include specimen quality, fill volume, clotting, hemolysis, gel performance, analyzer flags, label readability, staff usability, and patient experience.
Direct Manufacturer Purchasing Versus Distributor Purchasing
Direct manufacturer purchasing may offer stronger technical support, customized contracts, product training, and potentially lower pricing for high-volume systems. It may also require larger minimum orders, more complex logistics, longer contract commitments, and separate relationships for different product categories.
Distributor purchasing generally offers convenience, product variety, consolidated delivery, and access to multiple brands. Distributors can be especially helpful for smaller organizations that do not have the volume or staff to manage direct contracts. The tradeoff may be less direct access to technical representatives or less control over substitutions during shortages.
Many hospital systems use a blended model. They purchase core blood collection products through a negotiated manufacturer or distributor agreement while buying lower-volume specialty items through a secondary distributor. This approach can balance standardization with flexibility, provided that all alternatives are approved by the laboratory and infection-prevention team.
Group Purchasing Organizations and Contract Procurement
Large U.S. hospitals frequently purchase through group purchasing organizations, commonly called GPOs. GPOs negotiate contracts on behalf of member hospitals and health systems. The arrangement can improve purchasing leverage and simplify supplier selection, although contract participation does not automatically guarantee product availability or the lowest total cost for every facility.
Hospitals should determine whether a supplier is on an approved GPO contract, whether the specific product is contract-compliant, and whether local purchases qualify for the negotiated price. They should also review administrative fees, tier requirements, conversion obligations, rebate structures, freight terms, and product-substitution language.
Clinical stakeholders should participate in GPO-related decisions. A product selected solely for price may be unsuitable for a specific analyzer, patient population, or collection protocol. Procurement, laboratory leadership, nursing, infection prevention, employee health, and finance should have clearly defined roles in the evaluation.
Questions to Ask Potential Suppliers
- What manufacturer and exact catalog number correspond to the quoted product?
- Is the product intended and labeled for professional clinical use in the United States?
- What are the additive, fill volume, material, sterility status, and expiration requirements?
- Has the product been evaluated with the hospital’s analyzers, transport system, and laboratory procedures?
- What safety-engineering feature does the device use, and how is it activated?
- Where is the product manufactured, and what is the typical lead time?
- What happens if the item is back ordered or allocated?
- Will the supplier substitute another manufacturer or model without written approval?
- Can the supplier provide lot traceability, recall notifications, and quality documentation?
- What are the minimum order quantity, case quantity, freight charge, and return terms?
- Does the supplier support electronic ordering, barcode inventory, or automated replenishment?
- What training and technical support are available during product conversion?
Trends Affecting Phlebotomy Purchasing
Several trends are influencing the U.S. market. First, hospitals are increasing the use of safety-engineered devices in response to occupational-exposure requirements and employee-safety goals. Second, barcode identification and electronic specimen tracking are becoming more important as organizations work to reduce patient-identification errors and specimen mislabeling.
Third, pediatric and geriatric collection products are receiving greater attention. Small-volume tubes and low-dead-space devices can help reduce blood loss and redraws, especially for neonatal and critically ill patients. However, these products must be validated for the intended tests and analyzer requirements.
Fourth, environmental considerations are affecting packaging and waste decisions. Hospitals are asking suppliers to reduce unnecessary packaging, improve case configuration, and provide information about recyclable materials. Any sustainability initiative must still preserve sterility, product protection, traceability, and regulatory compliance.
Finally, supply-chain resilience remains a central concern. Healthcare organizations are examining domestic production, regional distribution, multiple approved manufacturers, and inventory visibility. The experience of pandemic-era shortages demonstrated that a resilient sourcing strategy is not merely a finance issue; it directly affects patient care and laboratory operations.
Recommended Purchasing Strategy for U.S. Hospitals
A practical strategy begins with a consumption analysis. The hospital should review historical usage by department, product, patient population, and testing category. It should identify peak-demand periods, emergency-stock requirements, expired inventory, product waste, specimen-rejection rates, and products that frequently go on allocation.
Next, the organization should divide supplies into standard, specialty, and critical categories. Standard products may include routine serum and EDTA tubes. Specialty products may include trace-element tubes, pediatric devices, or specialized blood-gas collection products. Critical products are those for which a shortage could interrupt essential testing or create an immediate safety concern.
The hospital can then request proposals from a combination of major distributors and specialized manufacturers. Proposals should be evaluated using a weighted scorecard covering price, quality, product performance, delivery, safety, technical support, documentation, and continuity planning.
Before full conversion, the hospital should conduct a pilot at one or more collection sites. The pilot should involve the people who actually draw blood and process specimens. Feedback from phlebotomists, nurses, laboratory technologists, infection-prevention staff, and patients can reveal practical problems that are not visible in a written proposal.
After implementation, the hospital should monitor key performance indicators. Useful measures include redraw rates, hemolysis rates, clotted-specimen rates, insufficient-volume rates, needlestick incidents, stockouts, expired inventory, emergency orders, and delivery accuracy. Reviewing these measures quarterly helps determine whether a supplier is delivering the expected value.
Conclusion
U.S. hospitals can purchase hospital-grade phlebotomy supplies from major distributors such as McKesson Medical-Surgical, Medline, Cardinal Health, and Henry Schein Medical, as well as directly or indirectly from specialized manufacturers including BD, Greiner Bio-One, Terumo Blood and Cell Technologies, Sarstedt, and Puritan Medical Products.
The right supplier is not necessarily the one with the largest catalog or the lowest quoted price. A strong supplier should provide compliant products, dependable availability, accurate documentation, responsive technical support, and products that work with the hospital’s laboratory systems. Procurement teams should also recognize that “hospital-grade” is a practical marketing description rather than a universal regulatory category.
The most reliable purchasing decision combines manufacturer and distributor research with laboratory validation, occupational-safety review, supply-chain planning, and total-cost analysis. By standardizing specifications, approving alternatives in advance, and monitoring product performance after implementation, healthcare organizations can purchase phlebotomy supplies that support patient safety, employee protection, Specimen Integrity, and uninterrupted clinical testing.
Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on the topics. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.